Inflammation Models | Charles River Discovery Research Services

Immunostimulation Model 

The immunostimulation model can be utilized to assess a drug candidate’s ability to reduce the ability of T cells to induce antibody production against an antigenic challenge. In this model, animals are administered either TNP-OVA in alum or KLH via intraperitoneal injection. A blood sample is taken and processed for antigen-specific IgM and IgG levels.

For more information about our immunostimulation model, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 17-juin 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th Europea...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Seri...
view all
RMS Specialist Montreal, Canada

Charles River Laboratories, Inc.